ACW actinogen medical limited

EU regulators reject Leqembi for Alzheimers

  1. 1,993 Posts.
    lightbulb Created with Sketch. 104
    The European Medicines Agency’s Committee for Medicinal Products for Human Use found that Leqembi’s benefits do not outweigh the risks of severe side effects associated with the treatment.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $82.60M
Open High Low Value Volume
2.5¢ 2.6¢ 2.5¢ $22.66K 897.6K

Buyers (Bids)

No. Vol. Price($)
5 522475 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 650495 6
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.